2,645 Shares in The Clorox Company (NYSE:CLX) Bought by Meridian Wealth Management LLC

Meridian Wealth Management LLC acquired a new position in shares of The Clorox Company (NYSE:CLX) in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 2,645 shares of the company’s stock, valued at approximately $431,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Studio Investment Management LLC bought a new position in Clorox during the 3rd quarter worth $419,000. Charles Schwab Investment Management Inc. grew its stake in Clorox by 1.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock worth $117,932,000 after buying an additional 13,038 shares during the last quarter. Intech Investment Management LLC grew its stake in Clorox by 14.6% during the 3rd quarter. Intech Investment Management LLC now owns 28,370 shares of the company’s stock worth $4,622,000 after buying an additional 3,615 shares during the last quarter. Bellwether Advisors LLC bought a new position in Clorox during the 3rd quarter worth $1,659,000. Finally, Darwin Wealth Management LLC bought a new position in Clorox during the 3rd quarter worth $73,000. 78.53% of the stock is currently owned by institutional investors.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.57% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research analysts recently commented on CLX shares. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and upped their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft boosted their price target on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and boosted their price target for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. JPMorgan Chase & Co. boosted their price target on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Finally, Citigroup boosted their price target on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $155.00.

Clorox Trading Up 0.1 %

Shares of Clorox stock opened at $169.30 on Monday. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The firm has a market cap of $20.96 billion, a price-to-earnings ratio of 58.99, a price-to-earnings-growth ratio of 3.13 and a beta of 0.41. The business has a fifty day simple moving average of $162.78 and a 200-day simple moving average of $148.54. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.35.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the business posted $0.49 earnings per share. Clorox’s revenue was up 27.0% compared to the same quarter last year. On average, equities analysts forecast that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.88%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is 170.04%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.